Sciwind Biosciences Completes Enrollment in Phase 2 Clinical Trial of XW003 in Type 2 Diabetes Patients
HANGZHOU, China and SAN FRANCISCO, Dec. 9, 2021 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat metabolic disease, today announced the completion of patient enrollment in its Phase 2 clinical trial of XW003 in type 2 diabetes patients in China. XW003 is a novel, long-lasting glucagon-like peptide-1...
Frost & Sullivan Honors Disruptive Organizations in the Region with Prestigious Industry Awards
16 companies will be recognized at the final Frost & Sullivan Virtual Awards Ceremony of the year, which will be broadcasted live on YouTube at 6:00 p.m. (GMT +8), 16 December 2021. SINGAPORE, Dec. 9, 2021 /PRNewswire/ -- Frost & Sullivan Best Practices Awards will be honoring 16 leading organizations on 16 December at the fourth and final virtual awards...
Another clean interim safety review of RhoVac’s clinical phase IIb study in prostate cancer
HELSINKI, Dec. 9, 2021 /PRNewswire/ -- RhoVac AB ("RhoVac"), a Swedish cancer immunotherapy company, announces today on December 9th, 2021, that its Data & Safety Monitoring Committee (DSMC) has conducted a planned interim safety review of its clinical phase IIb trial in prostate cancer, known as BRaVac. All patients have now been recruited into the study. The safety profile...
Proximie Partners with Jhpiego in New Initiative to Improve Obstetric Surgical Care
- The Obstetric Safe Surgery (OSS) Project in Kenya is funded by Johnson & Johnson and to date has been implemented by Jhpiego as the lead organization, in collaboration with County and National Ministries of Health and professional associations. - To support implementation moving forward, Proximie and Ariadne Labs have formed a unique partnership with Jhpiego to integrate Jhpiego's...
Posters Highlighting clinical data of KN026 presented at SABCS 2021
SUZHOU, China, Dec. 9, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. (stock code: 1093.HK) jointly announced that two posters highlighting data from two clinical studies of the anti-HER2 bispecific antibody KN026 were presented at the 44th San Antonio Breast Cancer Symposium (SABCS 2021). Title: Preliminary Safety and Efficacy Results of KN026 (a...
Bora Pharmaceuticals collaborates with Taishin Holdings to launch CDMO investment and M&A plan
TAIPEI, Taiwan, Dec. 9, 2021 /PRNewswire/ -- Bobby Sheng, chairman of Bora Pharmaceuticals (6472.TWO), today announced a partnership with Taishin Healthcare Limited Partnership at the 2021 Biotech Investor Forum, whereby the two parties will jointly invest up to NT$3 billion (approx. US$108 million) to target forward-looking contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs), in response to...
Lunit Named to the 2021 CB Insights Digital Health 150 — List of Most Innovative Digital Health Startups
SEOUL, South Korea, Dec. 9, 2021 /PRNewswire/ -- CB Insights today named Lunit to its third annual Digital Health 150, which showcases the 150 most promising private digital health companies in the world. This year's Digital Health 150 was unveiled live during CB Insights' annual Future of Health event. ...
Positive EMERALD Trial Results for Elacestrant Presented at San Antonio Breast Cancer Symposium 2021
- Trial met both primary endpoints demonstrating statistically significant and clinically meaningful extension of progression free survival (PFS) as monotherapy vs. standard of care (SoC) endocrine therapy in overall population and estrogen receptor mutation (mESR1) population - In the overall population, elacestrant reduced risk of progression or death by 30% vs. SoC -...
WuXi AppTec Receives 2021 Global Customer Value Leadership Award from Frost & Sullivan
SHANGHAI, Dec. 9, 2021 /PRNewswire/ -- WuXi AppTec, a leading global provider of R&D and manufacturing services that enable the global pharmaceutical and healthcare industry, announced that it is a recipient of the 2021 Global CRDMO Customer Value Leadership Award from Frost & Sullivan, a global research & consulting firm that helps clients accelerate growth. This marks the fifth consecutive year...
Nobel Prize laureates looked into the future of technologies at Nobel Vision
MOSCOW, Dec. 9, 2021 /PRNewswire/ -- Laureates of the Nobel, Wolf, Abel Prizes and the Fields Medal, leading Russian and foreign scientists, futurologists, participants of Thinkers50 rating, representatives of the authorities and innovative businesses have kept their vision of the future of technologies in a "Time Capsule". By the end of 2022 it will be announced whether the...
